Skip to main content
SleepCited

Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico.

Flor Cristina Ortiz Rios, Itzel Guadalupe Dávila Ruiz, Elisa Sacal Dumani
Case Report Drugs in context 2022 6 次引用
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'pmid\u003D36188636'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

研究类型
Case Reports
样本量
3
研究人群
Patients with anxiety disorders in Mexico
干预措施
Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico. None
对照组
None
主要结局
Anxiety symptom improvement
效应方向
Positive
偏倚风险
High

Abstract

Anxiety-related disorders are one of the most common mental health issues worldwide. Mexico has reported an increase in the prevalence of these ailments secondary to the confinement derived from the COVID-19 pandemic. Given the limitations of commonly used treatments for these disorders, a need arises to develop new pharmacological treatments for these patients. This paper has the primary objective of evaluating the efficacy and safety of cannabidiol isolate in drug compounding used as a personalized treatment in patients with anxiety disorders through the presentation of four clinical cases.

简要概述

Evaluating the efficacy and safety of cannabidiol isolate in drug compounding used as a personalized treatment in patients with anxiety disorders through the presentation of four clinical cases is evaluated.

Used In Evidence Reviews

Similar Papers